000 | 01627 a2200481 4500 | ||
---|---|---|---|
005 | 20250514080539.0 | ||
264 | 0 | _c20040212 | |
008 | 200402s 0 0 rus d | ||
022 | _a0372-9311 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBondarenko, V M | |
245 | 0 | 0 |
_a[Role of persisting opportunistic bacteria in the pathogenesis of the gastric and duodenum ulcer]. _h[electronic resource] |
260 |
_bZhurnal mikrobiologii, epidemiologii i immunobiologii _c |
||
300 |
_a11-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 |
_aAntifungal Agents _xpharmacology |
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 |
_aCandida _xdrug effects |
650 | 0 | 4 |
_aChitin _xanalogs & derivatives |
650 | 0 | 4 | _aChitosan |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aDuodenal Ulcer _xdrug therapy |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastric Mucosa _xmicrobiology |
650 | 0 | 4 |
_aHelicobacter Infections _xdrug therapy |
650 | 0 | 4 |
_aHelicobacter pylori _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntestinal Mucosa _xmicrobiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aStomach Ulcer _xdrug therapy |
650 | 0 | 4 |
_aStreptococcus _xdrug effects |
700 | 1 | _aChervinets, V M | |
700 | 1 | _aVorob'ev, A A | |
773 | 0 |
_tZhurnal mikrobiologii, epidemiologii i immunobiologii _gno. 4 _gp. 11-7 |
|
999 |
_c12734461 _d12734461 |